OptiBiotix Health Plc (AIM:OPTI)
10.70
-0.55 (-4.89%)
Jul 8, 2025, 3:07 PM GMT+1
OptiBiotix Health Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 0.74 | 0.64 | 1.05 | 2.01 | 0.86 | Upgrade
|
Cash & Short-Term Investments | 0.74 | 0.64 | 1.05 | 2.01 | 0.86 | Upgrade
|
Cash Growth | 16.38% | -39.64% | -47.58% | 132.11% | 89.79% | Upgrade
|
Accounts Receivable | 0.31 | 0.35 | 0.38 | 1.42 | 0.51 | Upgrade
|
Other Receivables | 0.13 | 0.19 | 0.24 | 0.27 | 0.42 | Upgrade
|
Receivables | 0.45 | 0.54 | 0.62 | 1.69 | 0.93 | Upgrade
|
Inventory | 0.23 | 0.19 | 0.18 | 0.1 | 0.18 | Upgrade
|
Prepaid Expenses | 0.01 | 0.02 | 0.01 | 0.06 | 0.02 | Upgrade
|
Total Current Assets | 1.42 | 1.38 | 1.86 | 3.85 | 2.01 | Upgrade
|
Long-Term Investments | 6.51 | 6.69 | 8.15 | 13.65 | 8.96 | Upgrade
|
Other Intangible Assets | 1.12 | 1.33 | 1.54 | 2.64 | 2.74 | Upgrade
|
Total Assets | 9.05 | 9.4 | 11.55 | 20.15 | 13.7 | Upgrade
|
Accounts Payable | 0.27 | 0.06 | 0.19 | 0.42 | 0.36 | Upgrade
|
Accrued Expenses | 0.06 | 0.08 | 0.07 | 0.18 | 0.16 | Upgrade
|
Other Current Liabilities | 0.04 | 0.05 | 0.02 | 0 | 0 | Upgrade
|
Total Current Liabilities | 0.37 | 0.18 | 0.28 | 0.6 | 0.52 | Upgrade
|
Long-Term Debt | - | - | - | 0.82 | 0.77 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.28 | 0.35 | 0.37 | 0.55 | 0.56 | Upgrade
|
Total Liabilities | 0.65 | 0.53 | 0.64 | 1.97 | 1.85 | Upgrade
|
Common Stock | 1.96 | 1.82 | 1.82 | 1.76 | 1.76 | Upgrade
|
Additional Paid-In Capital | 4.11 | 2.96 | 2.96 | 2.54 | 2.54 | Upgrade
|
Retained Earnings | 0.59 | 1.82 | 3.68 | 11.32 | 5.06 | Upgrade
|
Comprehensive Income & Other | 1.75 | 2.27 | 2.44 | 2.52 | 2.46 | Upgrade
|
Total Common Equity | 8.4 | 8.87 | 10.91 | 18.14 | 11.82 | Upgrade
|
Minority Interest | - | - | - | 0.04 | 0.04 | Upgrade
|
Shareholders' Equity | 8.4 | 8.87 | 10.91 | 18.17 | 11.85 | Upgrade
|
Total Liabilities & Equity | 9.05 | 9.4 | 11.55 | 20.15 | 13.7 | Upgrade
|
Total Debt | - | - | - | 0.82 | 0.77 | Upgrade
|
Net Cash (Debt) | 0.74 | 0.64 | 1.05 | 1.19 | 0.09 | Upgrade
|
Net Cash Growth | 16.38% | -39.64% | -11.45% | 1178.51% | - | Upgrade
|
Net Cash Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | Upgrade
|
Filing Date Shares Outstanding | 97.94 | 91.19 | 91.19 | 87.94 | 87.94 | Upgrade
|
Total Common Shares Outstanding | 97.94 | 91.19 | 91.19 | 87.94 | 87.94 | Upgrade
|
Working Capital | 1.06 | 1.2 | 1.58 | 3.25 | 1.49 | Upgrade
|
Book Value Per Share | 0.09 | 0.10 | 0.12 | 0.21 | 0.13 | Upgrade
|
Tangible Book Value | 7.28 | 7.54 | 9.37 | 15.5 | 9.08 | Upgrade
|
Tangible Book Value Per Share | 0.07 | 0.08 | 0.10 | 0.18 | 0.10 | Upgrade
|
Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.